Radiation Therapy Plus Gadolinium Texaphyrin in Treating Patients With Brain Metastases
Completed · Phase 3
Conditions studied: Metastatic Cancer
In brief
RATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells. Gadolinium texaphyrin may increase the effectiveness of radiation therapy by making tumor cells more sensitive to radiation. It is not yet known whether giving gadolinium texaphyrin with radiation therapy is more effective than radiation therapy alone in treating brain metastases. PURPOSE: Randomized phase III trial to compare the effectiveness of radiation therapy with or without gadolinium texaphyrin in treating patients who have brain metastases.
Key facts
- Study ID
- NCT00003563
- Run by
- Pharmacyclics LLC.
- People needed
- 430
- Starts
- 1998-08-01
- Expected to finish
- 2005-06-01
- Last updated by the study team
- 2013-10-31
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Marin Oncology Associates, Inc. — Greenbrae, California, United States
- Kaiser Permanente Medical Group — Los Angeles, California, United States
- Jonsson Comprehensive Cancer Center, UCLA — Los Angeles, California, United States
- Beckman Research Institute, City of Hope — Los Angeles, California, United States
- Radiation Oncology Center - Sacramento — Sacramento, California, United States
- University of Colorado Cancer Center — Denver, Colorado, United States
- Charlotte County Radiation Therapy Regional Center — Port Charlotte, Florida, United States
- Emory Clinic — Atlanta, Georgia, United States
- Indiana University Cancer Center — Indianapolis, Indiana, United States
- Hematology and Oncology Services - Metairie — Metairie, Louisiana, United States
- Massachusetts General Hospital Cancer Center — Boston, Massachusetts, United States
- Barbara Ann Karmanos Cancer Institute — Detroit, Michigan, United States
- Harper Hospital and Wayne State University — Detroit, Michigan, United States
- Veterans Affairs Medical Center - Minneapolis — Minneapolis, Minnesota, United States
- North Memorial Research Center — Minneapolis, Minnesota, United States
- Cancer Institute of New Jersey — New Brunswick, New Jersey, United States
- New Mexico Oncology-Hematology — Albuquerque, New Mexico, United States
- Memorial Sloan-Kettering Cancer Center — New York, New York, United States
- Barrett Cancer Center, The University Hospital — Cincinnati, Ohio, United States
- Cleveland Clinic Taussig Cancer Center — Cleveland, Ohio, United States
- Abington Hematology Oncology Associates — Meadowbrook, Pennsylvania, United States
- Kimmel Cancer Center of Thomas Jefferson University - Philadelphia — Philadelphia, Pennsylvania, United States
- Presbyterian-University Hospital — Pittsburgh, Pennsylvania, United States
- Mercy Hospital Cancer Center - Scranton — Scranton, Pennsylvania, United States
- Thompson Cancer Survival Center — Knoxville, Tennessee, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.